CN103704799A - Yacon and ginkgo biloba health care beverage - Google Patents
Yacon and ginkgo biloba health care beverage Download PDFInfo
- Publication number
- CN103704799A CN103704799A CN201210373901.6A CN201210373901A CN103704799A CN 103704799 A CN103704799 A CN 103704799A CN 201210373901 A CN201210373901 A CN 201210373901A CN 103704799 A CN103704799 A CN 103704799A
- Authority
- CN
- China
- Prior art keywords
- smallantus sonchifolium
- yacon
- beverage
- ginkgo
- care beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000008100 Ginkgo biloba Nutrition 0.000 title claims abstract description 20
- 235000013361 beverage Nutrition 0.000 title claims abstract description 13
- 244000194101 Ginkgo biloba Species 0.000 title abstract 3
- 244000134540 Polymnia sonchifolia Species 0.000 title abstract 3
- 235000003406 Polymnia sonchifolia Nutrition 0.000 title abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims abstract description 4
- 108010010803 Gelatin Proteins 0.000 claims abstract description 4
- 229920002907 Guar gum Polymers 0.000 claims abstract description 4
- 229920000159 gelatin Polymers 0.000 claims abstract description 4
- 239000008273 gelatin Substances 0.000 claims abstract description 4
- 235000019322 gelatine Nutrition 0.000 claims abstract description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 4
- 239000000665 guar gum Substances 0.000 claims abstract description 4
- 229960002154 guar gum Drugs 0.000 claims abstract description 4
- 235000010417 guar gum Nutrition 0.000 claims abstract description 4
- 239000004302 potassium sorbate Substances 0.000 claims abstract description 4
- 229940069338 potassium sorbate Drugs 0.000 claims abstract description 4
- 235000010241 potassium sorbate Nutrition 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 235000011201 Ginkgo Nutrition 0.000 claims description 17
- 241000218628 Ginkgo Species 0.000 claims description 17
- 241000133134 Saussurea Species 0.000 claims description 9
- 235000015203 fruit juice Nutrition 0.000 claims description 9
- 238000002386 leaching Methods 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 238000011049 filling Methods 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 4
- -1 0.12% Substances 0.000 claims description 3
- 235000005979 Citrus limon Nutrition 0.000 claims description 3
- 244000131522 Citrus pyriformis Species 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 238000000265 homogenisation Methods 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 12
- 210000004185 liver Anatomy 0.000 abstract description 4
- 230000036772 blood pressure Effects 0.000 abstract description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 230000003796 beauty Effects 0.000 abstract 1
- 229960004106 citric acid Drugs 0.000 abstract 1
- 235000015165 citric acid Nutrition 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 235000020510 functional beverage Nutrition 0.000 abstract 1
- 229940014259 gelatin Drugs 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 239000008213 purified water Substances 0.000 abstract 1
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 5
- 241000700199 Cavia porcellus Species 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 235000011957 flavonols Nutrition 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 229960001340 histamine Drugs 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- UFJORDZSBNSRQT-UHFFFAOYSA-N 3-(4-oxo-2-phenylchromen-3-yl)-2-phenylchromen-4-one Chemical compound O1C2=CC=CC=C2C(=O)C(C=2C(C3=CC=CC=C3OC=2C=2C=CC=CC=2)=O)=C1C1=CC=CC=C1 UFJORDZSBNSRQT-UHFFFAOYSA-N 0.000 description 2
- 101800004538 Bradykinin Proteins 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102100035792 Kininogen-1 Human genes 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 2
- 229910001626 barium chloride Inorganic materials 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 150000002216 flavonol derivatives Chemical class 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- BZFBDUQOBQHBSZ-DLCQERRASA-N (3s,8r,9s,10r,13s,14s,17s)-17-[3-(dimethylamino)propyl-methylamino]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol;dihydrochloride Chemical compound Cl.Cl.C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](N(C)CCCN(C)C)[C@@]1(C)CC2 BZFBDUQOBQHBSZ-DLCQERRASA-N 0.000 description 1
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- SQGLUEWZRKIEGS-UHFFFAOYSA-N Ginkgetin Natural products C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(OC)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 SQGLUEWZRKIEGS-UHFFFAOYSA-N 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930045534 Me ester-Cyclohexaneundecanoic acid Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000001466 anti-adreneric effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000008344 brain blood flow Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- AIFCFBUSLAEIBR-UHFFFAOYSA-N ginkgetin Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C(C=1)=CC=C(OC)C=1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 AIFCFBUSLAEIBR-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 229960001789 papaverine Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention relates to a beverage field, and especially relates to a yacon and ginkgo biloba health care beverage, which is prepared from the following raw materials: yacon, ginkgo biloba leach liquor, citric acid, gelatin, potassium sorbate, guar gum and purified water. The prepared product is a functional beverage having a composite medical effect, having efficacies of reducing blood glucose, maintaining beauty and keeping young, clearing liver, detoxifying, reducing blood pressure and blood fat, and having obvious health care effect on cardio cerebrovascular.
Description
Technical field
The present invention relates to field of beverage, refer in particular to a kind of Smallantus sonchifolium ginkgo leaves health-care beverage.
Background technology
Beverage market product is a lot of at present, each have their own function, in order further to enrich beverage market product diversity, practicality, with the healthy consideration of people, the technical problem to be solved in the present invention is to provide a kind ofly to be had compound property of medicine effect and has compound property of medicine effect and have recuperating gastrointestinal tract and reduce blood sugar, skin maintenance, clearing liver removing toxic substances, hypotensive, blood fat, cardiovascular and cerebrovascular reason is had to the drinks of obvious health-care effect.
Summary of the invention
The object of the invention is to, a kind of Smallantus sonchifolium ginkgo leaves health-care beverage is provided, adopts following technical scheme (adopt ingredients by weight ratio): a, raw material Smallantus sonchifolium 40-60 %, ginkgo leaf leaching liquor 5-15%, lemon picture acid 0.12% gelatin 1.5%, potassium sorbate 0.01%, guar gum 0.08%, water purification 30-50 standby; B, pretreatment: prepare Saussurea involucrate fruit juice, choose ripe Smallantus sonchifolium, clean up, pulverize.Put into jacketed pan, add the standby water purification of a, boil rear micro-boiling 2 hours, cross leaching juice, obtain Saussurea involucrate fruit juice; C, allotment: get a material-compound tank, by a and b gained ginkgo leaf leaching liquor, Saussurea involucrate fruit juice pump people tank, start and mix device, various feed liquids are evenly mixed; D, homogeneous: c gained mixed liquor is entered to high pressure homogenizer, and homogenization pressure is 18-22MPa; F, sterilization, filling d gained homogenizing fluid is entered to board-like sterilizer sterilization, sterilization conditions is 9O-95 ℃, is incubated 5-8 minutes, more filling, sealing while hot, is cooled to room temperature, good to eat Smallantus sonchifolium ginkgo leaves health-care beverage.
The invention has the beneficial effects as follows: by the joint of described Chinese medicine preparation and production technology, can make full use of the property of medicine of various medicines, what obtain has recuperating gastrointestinal tract and reduces blood sugar, skin maintenance, clearing liver removing toxic substances, hypotensive, blood fat, cardiovascular and cerebrovascular reason is had to the function of obvious health-care effect.
Smallantus sonchifolium: the FOS content of Smallantus sonchifolium is the 60-70% of dry, its content is the highest in all plants, also contains abundant mineral matter and calcium, magnesium, iron, zinc, potassium, selenium and other trace elements.Japanology is also found, takes the FOS of 3-6g every day, and within 3 weeks, in people's ight soil, the content of poisonous carcinogenic compound can reduce more than percent 40.Smallantus sonchifolium carbohydrate is seldom absorption of human body, is therefore well suited for diabetes patient and slimmer edible.FOS has: 1. promote digestion, recuperating gastrointestinal tract; 2. be the growth-promoting agent of useful flora in intestines, produce Oilgosaccharkdes; 3. nurse one's health blood, remove high fat of blood, effectively control cholesterol and diabetes; 4. defaecation, control diarrhea; 5. fiery detoxicating, control pimples, dark sore fall; 6. improve immunity.Its pharmacology is done use: can nurse one's health blood, reduce blood sugar, blood fat and cholesterol, prevention and treatment hypertension and diabetes, the elderly's cardiovascular and cerebrovascular diseases are had to obvious health-care effect, the FOS content of Smallantus sonchifolium is the highest in all plants, can help digest, coordinating intestines and stomach, treatment diarrhea, makes defecation unobstructed, is the jinx of enterogastritis, anti-inflammatory diuresis, keep urinary tract unimpeded, reduce calculus and carcinogenic toxins, clearing liver removing toxic substances, can effectively prevent the dark sore spot of face, be the natural health fruit of skin maintenance.
ginkgo leaf: return through the heart channel of Hang-Shaoyin; Lung channel; The spleen channel.Function: invigorate blood circulation and nourish heart, the puckery intestines of astringing the lung.Cure mainly: chest impediment and cardialgia; The phlegm of breathing with cough is coughed; Dysentery; Leukorrhea.A
, on cardiovascular impactthe flavonols Flavonol proposing from folium ginkgo bilobae (for the mixture of Quercetin, Kaempferol, Isorhamnetin) or ginkegetin class, to guinea pig isolated heart perfusion, can cause coronary vasodilation, be injected in the artery of cavy perfused hindquarter, expansible hind leg blood is sought, and the biflavone in leaf also has dilating effect to rat hindlimb blood vessel.The CE of leaf (every 1ml containing total flavone glucoside 4.263mg) can be to the in vitro rabbit ear due to antiadrenergic drug vasoconstrictor effects, a little less than the effect of general glycoside; To the 20-40 of anesthetized rabbit intramuscular injection quantity doubly, on blood pressure, breathe all without affecting.Ethanol extract is the same with flavonols, on cat, rabbit blood pressure, heart, breathing also without impact; As application is greater than blood vessel dilatation dosage 100-1000 flavonols doubly, be injected in cavy, can cause the step-down of medium degree, the increase of heart rate and breathing; Big white mouse is showed and boosted, but these changes are relevant with the impact of anesthesia, animal excitement, solvent, without real value.Extraction preparation oral or the intravenous injection of leaf, can make parkinson's disease patient's brain blood flow increase, and improves the nutrition of brain.B
, the effect to smooth muscleflavonols or ginkegetin class have spasmolysis to guinea pig in vitro intestinal tube, have the effect of antagonism bradykinin, the spasm that can also cause antihistaminicum and barium chloride, and its action intensity is similar to papaverine, but more lasting; The ethanol extract of leaf is to guinea-pig isolated trachea and ileum, the convulsion effect that causes of energy antagonism histamine and acetylcholine, in intestinal tube experiment, also can resist the effect of barium chloride, lumbar injection can be prevented the Experimental Asthma In Guinea-pigs due to histamine, the flavonoids thing of ginkgo leaf is in Guinea pig lung overflow experiment or histamine spraying experiment, and performance has dilating effect to bronchus.Biflavone in leaf has spasmolysis to intestinal tube spasm due to bradycardia element Bradykinin.C
, other effects: the tablet that contains flavones, ginkgetin, ginkegetin, hypercholesterolemia patient, like reducing serum ornitrol level, rising phosphatide, is improved to C/P ratio, hypertensive patient is seemingly had to certain hypotensive effect, but amplitude is little.Preliminary test tube test has bacteriostasis to Pseudomonas aeruginosa, staphylococcus aureus, shigella dysenteriae.The alkaloid of isolating from ginkgo bark has the effect of vasoconstriction and expansion pupil.
The specific embodiment
Below in conjunction with a preferred embodiment, invention is further elaborated technical scheme production craft step provided by the invention following (adopting ingredients by weight ratio): a, raw material Smallantus sonchifolium 50 %, ginkgo leaf leaching liquor 10%, lemon picture acid 0.12%, gelatin 1.5%, potassium sorbate 0.01%, guar gum 0.08%, water purification 38.29% are standby; B, pretreatment: prepare Saussurea involucrate fruit juice, choose ripe Smallantus sonchifolium, clean up, pulverize.Put into jacketed pan, add the standby water purification of a, boil rear micro-boiling 2 hours, cross leaching juice, obtain Saussurea involucrate fruit juice; C, allotment: get a material-compound tank, by a and b gained ginkgo leaf leaching liquor, Saussurea involucrate fruit juice pump people tank, start and mix device, various feed liquids are evenly mixed; D, homogeneous: c gained mixed liquor is entered to high pressure homogenizer, and homogenization pressure is 18-22MPa; F, sterilization, filling d gained homogenizing fluid is entered to board-like sterilizer sterilization, sterilization conditions is 9O-95 ℃, is incubated 5-8 minutes, more filling, sealing while hot, is cooled to room temperature, good to eat Smallantus sonchifolium ginkgo leaves health-care beverage.
The above, be only the specific embodiment of the present invention, but protection scope of the present invention is not limited to this, and any variation of expecting without creative work or replacement, within all should being encompassed in protection scope of the present invention.Therefore, protection scope of the present invention should be as the criterion with the protection domain that claims were limited.
Claims (1)
1. a Smallantus sonchifolium ginkgo leaves health-care beverage, adopts following technical scheme (adopting ingredients by weight ratio): a, raw material Smallantus sonchifolium 40-60 %, ginkgo leaf leaching liquor 5-15%, lemon picture acid, 0.12%, gelatin 1.5%, potassium sorbate 0.01%, guar gum 0.08%, water purification 30-50 standby; B, pretreatment: prepare Saussurea involucrate fruit juice, choose ripe Smallantus sonchifolium, clean up, pulverize, put into jacketed pan, add the standby water purification of a, boil rear micro-boiling 2 hours, cross leaching juice, obtain Saussurea involucrate fruit juice; C, allotment: get a material-compound tank, by a and b gained ginkgo leaf leaching liquor, Saussurea involucrate fruit juice pump people tank, start and mix device, various feed liquids are evenly mixed; D, homogeneous: c gained mixed liquor is entered to high pressure homogenizer, and homogenization pressure is 18-22MPa; F, sterilization, filling d gained homogenizing fluid is entered to board-like sterilizer sterilization, sterilization conditions is 9O-95 ℃, is incubated 5-8 minutes, more filling, sealing while hot, is cooled to room temperature, good to eat Smallantus sonchifolium ginkgo leaves health-care beverage.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210373901.6A CN103704799A (en) | 2012-10-05 | 2012-10-05 | Yacon and ginkgo biloba health care beverage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210373901.6A CN103704799A (en) | 2012-10-05 | 2012-10-05 | Yacon and ginkgo biloba health care beverage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103704799A true CN103704799A (en) | 2014-04-09 |
Family
ID=50398470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210373901.6A Pending CN103704799A (en) | 2012-10-05 | 2012-10-05 | Yacon and ginkgo biloba health care beverage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103704799A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104273616A (en) * | 2014-10-25 | 2015-01-14 | 湖南馨恒堂中药科技有限公司 | Yacon drink and preparation method thereof |
| CN106107295A (en) * | 2016-07-18 | 2016-11-16 | 南昌大学 | A kind of have beverage and the preparation method strengthening gut barrier function |
| CN106923106A (en) * | 2017-03-22 | 2017-07-07 | 张红霞 | A kind of Saussurea involucrate fruit juice beverage and preparation method thereof |
-
2012
- 2012-10-05 CN CN201210373901.6A patent/CN103704799A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104273616A (en) * | 2014-10-25 | 2015-01-14 | 湖南馨恒堂中药科技有限公司 | Yacon drink and preparation method thereof |
| CN104273616B (en) * | 2014-10-25 | 2017-01-11 | 湖南馨恒堂中药科技有限公司 | Yacon drink and preparation method thereof |
| CN106107295A (en) * | 2016-07-18 | 2016-11-16 | 南昌大学 | A kind of have beverage and the preparation method strengthening gut barrier function |
| CN106923106A (en) * | 2017-03-22 | 2017-07-07 | 张红霞 | A kind of Saussurea involucrate fruit juice beverage and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100401925C (en) | Making method of health-care beverage for efficient preventing and treating asthma | |
| KR101594137B1 (en) | composition for health functional food improving joint health | |
| CN103446385B (en) | Traditional Chinese medicine preparation for treating diabetic complications | |
| CN102038260B (en) | Chinese medicinal alcoholism relieving health-care beverage and preparation method thereof | |
| KR101544570B1 (en) | Beverage composition for eliminating hangover and improvement of hepatic function | |
| KR101202988B1 (en) | Healthy beverage and its manufacturing method | |
| CN103704799A (en) | Yacon and ginkgo biloba health care beverage | |
| KR20120131337A (en) | A functional beverage composition of extract of Artemisia iwayomogi, extract of Hovenia dulcis, extract of Taraxacum mongolicum, extract of Jujube, extract of Pueraria lobata and extract of Acanthopanax sessiliflorum as main ingredients | |
| KR101835416B1 (en) | Composition for preventing stroke using the natural | |
| CN111387345A (en) | Compound polysaccharide composition and preparation method thereof | |
| CN105285288A (en) | Creamy candy assisting in treating pharyngolaryngitis and preparation method of creamy candy | |
| CN108969591A (en) | A kind of preparation purifying blood | |
| CN108057115A (en) | A kind of composition for treating inflammation of upper respiratory tract infection and preparation method thereof | |
| CN101708029A (en) | Feed mainly prepared from ginkgo biloba leaves | |
| CN103704825A (en) | Eucommia and ginkgo health care beverage | |
| CN107233491A (en) | It is a kind of to improve the antifatigue maca composition of energy | |
| CN103828973A (en) | Jasmine flower weight-reducing tea | |
| CN103495115B (en) | A kind of to the medicative medicated wine of diabetes tool | |
| CN1082353C (en) | Biological fungus beverage containing saussurea involucrata | |
| CN112076305A (en) | A Chinese medicinal oral and topical stock solution mixture for treating metabolic syndrome and resisting bacteria and inflammation | |
| CN104585769B (en) | A kind of compound product containing allicin and preparation method thereof | |
| CN109289017A (en) | For clearing up the composition and preparation method of blood vessel and blood | |
| RU2407537C1 (en) | Method for treatment and prevention of gastrointestinal disturbances and pulmonary diseases in young animals and birds | |
| CN103704823A (en) | Folium ginkgo, liquorice and matrimony vine health care beverage | |
| CN106617038A (en) | Health-care food composition for relieving male frequent urination and urinary incontinence as well as preparation method and application of health-care food composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140409 |